Concepedia

Muhammad Junaid Niaz

MJ

Statistics

Publications

11

Citations

264

H-Index

10

Active since

2017

Affiliations

Cornell University(Current)

Weill Cornell Medicine

Molecular Innovations (United States)

Muhammad Junaid Niaz is an author at Cornell University specializing in radiation oncology, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2017–2022

11

Publications

11

Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

Jaspreet S. Batra, Muhammad Junaid Niaz, Young E. Whang et al. · Urologic Oncology Seminars and Original Investigations · 2020 · 45 citations

, , +4

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer

Panagiotis J. Vlachostergios, Muhammad Junaid Niaz, Michael Sun et al. · Frontiers in Oncology · 2021 · 41 citations · Full text

Pilot Study of Hyperfractionated Dosing of Lutetium-177–Labeled Antiprostate-Specific Membrane Antigen Monoclonal Antibody J591 (177Lu-J591) for Metastatic Castration-Resistant Prostate Cancer

Muhammad Junaid Niaz, Jaspreet S. Batra, Ryan D. Walsh et al. · The Oncologist · 2020 · 36 citations · Full text

Phase I study of <sup>225</sup>Ac-J591 for men with metastatic castration-resistant prostate cancer (mCRPC).

Scott T. Tagawa, Michael Sun, Oliver Sartor et al. · Journal of Clinical Oncology · 2021 · 30 citations

, , +17

Imaging expression of prostate‐specific membrane antigen and response to PSMA‐targeted β‐emitting radionuclide therapies in metastatic castration‐resistant prostate cancer

Panagiotis J. Vlachostergios, Muhammad Junaid Niaz, Myrto Skafida et al. · The Prostate · 2021 · 25 citations · Full text

1–5 of 11